Jonathan Yon
Stock Analyst at Credit Suisse
(2.08)
# 2,977
Out of 5,154 analysts
16
Total ratings
54.55%
Success rate
4.87%
Average return
Main Sectors:
Stocks Rated by Jonathan Yon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Outperform | $163 → $169 | $192.65 | -12.28% | 3 | Jul 27, 2023 | |
| PRVA Privia Health Group | Reiterates: Outperform | $41 | $23.27 | +76.19% | 2 | Jun 22, 2023 | |
| CYH Community Health Systems | Maintains: Neutral | $8.5 → $7.4 | $3.35 | +120.90% | 1 | May 3, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $31 → $32 | $9.82 | +225.87% | 1 | Feb 23, 2023 | |
| SLQT SelectQuote | Maintains: Neutral | $1 → $3 | $0.76 | +297.30% | 1 | Feb 22, 2023 | |
| MD Pediatrix Medical Group | Maintains: Outperform | $27 → $23 | $19.75 | +16.46% | 3 | Feb 22, 2023 | |
| HCA HCA Healthcare | Maintains: Outperform | $296 → $260 | $532.81 | -51.20% | 1 | Apr 25, 2022 | |
| CLOV Clover Health Investments | Downgrades: Underperform | $9 → $3.5 | $2.00 | +75.00% | 2 | Jan 7, 2022 | |
| CI The Cigna Group | Maintains: Outperform | $270 → $300 | $271.63 | +10.44% | 1 | Nov 8, 2021 | |
| CNC Centene | Maintains: Neutral | $74 → $70 | $43.65 | +60.37% | 1 | Sep 14, 2021 |
Universal Health Services
Jul 27, 2023
Maintains: Outperform
Price Target: $163 → $169
Current: $192.65
Upside: -12.28%
Privia Health Group
Jun 22, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.27
Upside: +76.19%
Community Health Systems
May 3, 2023
Maintains: Neutral
Price Target: $8.5 → $7.4
Current: $3.35
Upside: +120.90%
Cross Country Healthcare
Feb 23, 2023
Maintains: Neutral
Price Target: $31 → $32
Current: $9.82
Upside: +225.87%
SelectQuote
Feb 22, 2023
Maintains: Neutral
Price Target: $1 → $3
Current: $0.76
Upside: +297.30%
Pediatrix Medical Group
Feb 22, 2023
Maintains: Outperform
Price Target: $27 → $23
Current: $19.75
Upside: +16.46%
HCA Healthcare
Apr 25, 2022
Maintains: Outperform
Price Target: $296 → $260
Current: $532.81
Upside: -51.20%
Clover Health Investments
Jan 7, 2022
Downgrades: Underperform
Price Target: $9 → $3.5
Current: $2.00
Upside: +75.00%
The Cigna Group
Nov 8, 2021
Maintains: Outperform
Price Target: $270 → $300
Current: $271.63
Upside: +10.44%
Centene
Sep 14, 2021
Maintains: Neutral
Price Target: $74 → $70
Current: $43.65
Upside: +60.37%